News & Events

News / press releases

€ 38.7 Mio. German government funding for the clinical development of a Corona medication

CORAT has been awarded additional funding

CORAT Therapeutics GmbH announces partnership with Dermapharm Holding SE

CORAT Therapeutics GmbH announces partnership with Dermapharm Holding SE

CORAT antibody COR-101 binds and inhibits all B.1.617 SARS-CoV-2 variants, including the fast proliferating “delta” variant

CORAT antibody COR-101 recognizes the current “Indian” mutant B.1.617

CORAT Therapeutics secures additional funding for Phase II clinical evaluation of its COVID-19 treatment

CORAT Therapeutics secures additional funding

Load More

events / conferences

events 2021

link

BIO Europe 2021

October 25 – 28, 2021 | Virtual

PEGS Boston 2021

June 10 – 18, 2021 | Virtual

Biologics Europe 2021

April 25 – 28, 2021 | Virtual